Roche Evrysdi gets CHMP recommendation for babies under two months old with spinal muscular atrophy Ruchika Sharma24 July 2023 3:30 PM ISTEvrysdi is currently approved in the EU for the treatment of patients aged two months or older,
Roche, Alnylam collaborate for hypertension therapy Ruchika Sharma24 July 2023 12:29 PM ISTUnder the terms of the agreement, Alnylam will receive an upfront payment of USD 310m and is eligible to receive development, regulatory and...
Roche announces positive phase III results for Ocrevus twice a year, 10-minute subcutaneous injection in multiple sclerosis patients Ruchika Sharma16 July 2023 2:30 PM ISTBasel: Roche has announced that the Phase III OCARINA II trial evaluating OCREVUS (ocrelizumab) as a twice a year 10-minute subcutaneous injection met...
Roche gets European Commission nod for fixed duration Columvi for diffuse large B-cell lymphoma Ruchika Sharma11 July 2023 4:30 PM ISTColumvi is a CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface of B-cells.
Revise CT Protocol: CDSCO Panel Tells Roche on Ophthalmic Drug RO7200220 Dr. Divya Colin10 July 2023 6:00 PM ISTNew Delhi: Responding to the drug major Roche's proposal to conduct a Phase III clinical trial of RO7200220, anti-interleukin-6 (IL-6), the Subject...
CDSCO Panel Approves Roche's Protocol Amendment Proposal to Study Polatuzumab Vedotin Dr. Divya Colin2 July 2023 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has approved the protocol amendment...
US FDA declines to approve Regeneron's higher dose Eylea Ruchika Sharma30 Jun 2023 11:00 AM ISTRegeneron was seeking approval for the drug to treat wet AMD, the leading cause of blindness among the elderly, and two eye diseases that are common...
Roche Gets CDSCO Panel Nod To study Anticancer FDC Pertuzumab, Trastuzumab Dr. Divya Colin25 Jun 2023 6:00 PM ISTNew Delhi: Based on the justification provided by the drug major Roche, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Roche gets USFDA nod for Columvi to treat relapsed or refractory diffuse large B cell lymphoma Ruchika Sharma18 Jun 2023 2:42 PM ISTColumvi is a CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface of B-cells.
Roche cobas HPV test gets WHO prequalification Ruchika Sharma13 Jun 2023 12:15 PM ISTThe cobas HPV test detects the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 6
Roche Holding plans to sell 800-employee drug manufacturing plant in Vacaville Ruchika Sharma4 Jun 2023 12:00 PM ISTThe company said it is seeking a buyer that will continue to use the plant as an operating facility.
Roche Canada, pan-Canadian Pharmaceutical Alliance complete negotiations for VABYSMO to treat Neovascular neovascular AMD, DME Ruchika Sharma30 May 2023 5:46 PM ISTVABYSMO is a humanized bispecific immunoglobulin G1(IgG1) antibody that acts through inhibition of both Ang-2 and vascular endothelial growth factor A...
